SEATTLE and VANCOUVER, British Columbia - Achieve Life Sciences, Inc. (NASDAQ:ACHV) announced today the publication of research in Nicotine & Tobacco Research examining cytisinicline’s receptor ...
SEATTLE and VANCOUVER, British Columbia, March 26, 2026 (GLOBE NEWSWIRE)-- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development ...
Preclinical findings show cytisinicline's minimal 5-HT3 serotonin receptor binding offers insight into observed low nausea rates in smoking and vaping cessation trials SEATTLE and VANCOUVER, British ...
Researchers found that intestinal tuft cells signal to crypt enterochromaffin cells by releasing acetylcholine, triggering serotonin release and activating a gut-to-brain vagal pathway during type 2 ...
Gan & Lee Pharmaceuticals (hereinafter referred to as Gan & Lee, SSE: 603087) announced the signing of an exclusive licensing ...
BACKGROUND: Despite antiplatelet therapy, some patients remain at high ischemic risk because of drug nonresponsiveness or high residual platelet reactivity). We aimed to target an orphan platelet GPCR ...
The strongest human data on psychedelic and cannabis co-use comes from a 2022 prospective survey study by Kuc et al.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results